Based on the forecasted data, the average length of stay for leiomyoma of the uterus in Canada shows a steady increase from 2024 to 2028. Starting at 2 days in 2024 and reaching 2.2 days by 2028, the progression indicates an annual growth pattern. From 2024 to 2026, the length of stay remains stable at 2 and 2.1 days, respectively, with a slight increase noted between 2026 and 2027. This consistent upward trend results in a compound annual growth rate (CAGR) over the five-year period that signifies a modest uplift in hospital stay durations for this condition.

Future trends to monitor include:

Advancements in medical treatments and practices that could reduce hospital stays.
Healthcare policy changes impacting hospital discharge procedures.
Technological innovations in surgery related to uterine leiomyoma.